News

New Drug Effective in Treating Vitreous Traction

Early treatment with a new drug called JETREA® (formerly called ocriplasmin) has shown effectiveness in lessening the risk of macular pucker, macular hole, and vitreomacular traction (VMT). These conditions are caused by the tugging on the macula by the vitreous gel, which is attached to the retina at several points. As the vitreous shrinks with [Read More]

Please Help Me, I'm Falling!

by Joe Fontenot MD, CLVT and Marie Cafferty LPTA, SARPC (Reprinted with permission from “The Magnifier”, a publication of MD Foundation.) Common sense, as well as the Mr. McGoo cartoons, tells us that poor vision makes it more likely to fall. Medical studies bear this out. Falls are serious and frequent events. According to a [Read More]

Legislation Agreed Upon to Address High-Risk Drug Compounding Practices

WASHINGTON, DC – Leaders from the Senate and House committees overseeing health policy today announced that they have reached an agreement on legislation to help ensure the safety of compounded drugs and our nation’s pharmaceutical supply chain. This legislation, the Drug Quality and Security Act, reflects a bipartisan, bicameral effort to improve drug safety and [Read More]

Non-Mydriatic Retinal Cameras Offer Safer Examination

by Liz Trauernicht, Director MD Foundation A significant amount of evidence finds that very bright light, especially blue light, can damage the macula. Traditional slit lamp devices used during eye exams produce high light levels, which may be problematic for people with macular degeneration. Before these devices can be used effectively, the pupil of the [Read More]